Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

CT694 and pgp3 as serological tools for monitoring trachoma programs.

Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ.

PLoS Negl Trop Dis. 2012;6(11):e1873. doi: 10.1371/journal.pntd.0001873.

2.

Serology for trachoma surveillance after cessation of mass drug administration.

Martin DL, Bid R, Sandi F, Goodhew EB, Massae PA, Lasway A, Philippin H, Makupa W, Molina S, Holland MJ, Mabey DC, Drakeley C, Lammie PJ, Solomon AW.

PLoS Negl Trop Dis. 2015 Feb 25;9(2):e0003555. doi: 10.1371/journal.pntd.0003555.

3.

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.

Goodhew EB, Morgan SM, Switzer AJ, Munoz B, Dize L, Gaydos C, Mkocha H, West SK, Wiegand RE, Lammie PJ, Martin DL.

BMC Infect Dis. 2014 Apr 22;14:216. doi: 10.1186/1471-2334-14-216.

4.

Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

Ghaem-Maghami S, Ratti G, Ghaem-Maghami M, Comanducci M, Hay PE, Bailey RL, Mabey DC, Whittle HC, Ward ME, Lewis DJ.

Clin Exp Immunol. 2003 Jun;132(3):436-42.

5.

The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.

Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK.

PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2761. doi: 10.1371/journal.pntd.0002761.

6.

Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.

Wills GS, Horner PJ, Reynolds R, Johnson AM, Muir DA, Brown DW, Winston A, Broadbent AJ, Parker D, McClure MO.

Clin Vaccine Immunol. 2009 Jun;16(6):835-43. doi: 10.1128/CVI.00021-09.

7.

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.

West SK, Munoz B, Weaver J, Mrango Z, Dize L, Gaydos C, Quinn TC, Martin DL.

PLoS Negl Trop Dis. 2016 Jan 15;10(1):e0004352. doi: 10.1371/journal.pntd.0004352.

8.

Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.

Pant BP, Bhatta RC, Chaudhary JS, Awasthi S, Mishra S, Sharma S, Cuddapah PA, Gwyn SE, Stoller NE, Martin DL, Keenan JD, Lietman TM, Gaynor BD.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004462. doi: 10.1371/journal.pntd.0004462.

9.

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1492-7.

PMID:
17389476
10.

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.

Burr SE, Hart JD, Edwards T, Baldeh I, Bojang E, Harding-Esch EM, Holland MJ, Lietman TM, West SK, Mabey DC, Sillah A, Bailey RL.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2347. doi: 10.1371/journal.pntd.0002347.

11.

Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.

Wolle MA, Muñoz BE, Mkocha H, West SK.

Ophthalmology. 2009 Feb;116(2):243-7. doi: 10.1016/j.ophtha.2008.09.011.

PMID:
19091415
12.

Mass treatment with single-dose azithromycin for trachoma.

Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.

N Engl J Med. 2004 Nov 4;351(19):1962-71.

14.

Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

Ghaem-Maghami S, Bailey RL, Mabey DC, Hay PE, Mahdi OS, Joof HM, Whittle HC, Ward ME, Lewis DJ.

Infect Immun. 1997 Dec;65(12):4958-64.

15.

Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.

Comanducci M, Manetti R, Bini L, Santucci A, Pallini V, Cevenini R, Sueur JM, Orfila J, Ratti G.

Infect Immun. 1994 Dec;62(12):5491-7.

16.

Serological response to pgp3 protein in animal and human chlamydial infections.

Donati M, Laroucau K, Storni E, Mazzeo C, Magnino S, Di Francesco A, Baldelli R, Ceglie L, Renzi M, Cevenini R.

Vet Microbiol. 2009 Mar 16;135(1-2):181-5. doi: 10.1016/j.vetmic.2008.09.037.

PMID:
18945555
17.

OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women.

Smith A, Muñoz B, Hsieh YH, Bobo L, Mkocha H, West S.

Ophthalmic Epidemiol. 2001 Jul;8(2-3):127-35.

PMID:
11471082
18.
19.

Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.

Campbell JP, Mkocha H, Munoz B, West SK.

Ophthalmic Epidemiol. 2012 Feb;19(1):38-42. doi: 10.3109/09286586.2011.627490.

PMID:
22273357
20.

Immune responses to Helicobacter pylori infection in children with intellectual disabilities.

Douraghi M, Goudarzi H, Nateghi Rostami M, Nikmanesh B.

Res Dev Disabil. 2012 Mar-Apr;33(2):663-9. doi: 10.1016/j.ridd.2011.11.010.

PMID:
22186633

Supplemental Content

Support Center